Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

Leukemia. 2009 Jul;23(7):1355-8. doi: 10.1038/leu.2009.72. Epub 2009 Apr 9.

Authors

H Kreyenberg, C Eckert, Y Yarkin, M Reising, A Willasch, R Handgretinger, B Kremens, A von Stackelberg, G Henze, T Klingebiel, P Bader

PMID: 19357703
DOI: 10.1038/leu.2009.72

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Biomarkers, Tumor*
Child
Child, Preschool
Gene Rearrangement*
Humans
Immunoglobulins / genetics*
Infant
Neoplasm, Residual / diagnosis*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
Receptors, Antigen, T-Cell / genetics*
Stem Cell Transplantation*

Substances

Biomarkers, Tumor
Immunoglobulins
Receptors, Antigen, T-Cell